SCRS Talks – Détails, épisodes et analyse

Join Dr. Michael Koren, CEO and Executive Director of MedEvidence, to explore how education and transparency can reshape the public’s understanding of clinical research. Dr. Koren shares his passion for putting patient welfare first and highlights how Med Evidence empowers individuals to make informed decisions about participating in trials. He discusses the importance of building trust, breaking down misconceptions, and helping communities see research as a valuable care option. Tune in to discover how storytelling, visibility, and patient engagement are helping redefine the relationship between the public and clinical research.

Sit down with Kate Shaw, Founder and CEO of Innovative Trials, to explore how humanized, bespoke approaches are reshaping patient recruitment and retention in clinical research. Kate breaks down the difference between one-to-one, in-country support and automated recruitment systems, showing how local expertise and cultural understanding can dramatically improve trial outcomes. You’ll also hear how the Patient Support Center and dedicated patient navigators guide participants step by step, ensuring they feel informed, respected, and cared for throughout the trial. This episode uncovers how personalized strategies not only boost recruitment success but also lighten the load for sites and create a more meaningful patient experience.

Early investment in proper training doesn't just benefit new staff—it strengthens your entire organization and the research ecosystem. SCRS is ready to tackle industry-wide training gaps, transforming research assistants, coordinators, and business teams into confident contributors. Learn how this foundational knowledge accelerates success and helps your team navigate challenges with clarity and purpose.

Save your seat today for the hands-on "Back to Basics" workshop at the Global Site Solutions Summit this September in Orlando. This intensive training equips research newcomers with must-have skills to thrive in clinical trials.

Andrew Kimball, Executive Vice President of Strategic Commercial Relationships at Velocity Clinical Research, highlights the growth and initiatives of his organization, which is currently the largest dedicated research site organization in the world. Andrew also shares insight on Velocity's acquisition of Meridian Clinical Research and the benefits of joining a site network.

What is the best way for clinical research sites to find new trials and establish productive industry relationships? Scott Whitt, General Manager of Triad Clinical Trials, discusses business development best practices that have worked for his site, and how sites can develop strategic industry alliances.

Todd Albin, Chief Executive Officer, Cedar Health Research, joins us to discuss a trend many clinical research sites have been experiencing with their budget and CTA negotiations with sponsors.

This episode will highlight how this practice impacts site sustainability, as well as our studies and our patients, and some ways sites and sponsors can come to a mutually beneficial solution.

 Access the SCRS Site Invoiceables Toolkit at myscrs.org/site-invoiceables-toolkit.

The SCRS Digital Innovation Initiative decentralized trials workstream recently released a Best Practices and Recommendations for Site Participation on Decentralized Trials guide. Deena Bernstein, Vice President Customer Success at Datacubed Health , and Karen McIntyre, Senior Director, Patient Innovation Centre at Parexel, share how this resource was developed and how sites can utilize it effectively. 

We'll also discuss what should sites consider before initiating a trial with decentralized elements, and advice for sites that may be hesitant to engage these types of technologies.

In this episode, we are proud to highlight our 2022 Eagle Award sponsor recipient,  Merck. Jennifer Sheller, AVP, Clinical Trial Operations Leader with Merck discusses some of the site-focused programs her organization put in motion to earn the award and their plans to progress those initiatives. Jennifer also discusses Merck's response to the SCRS Open Letter to Industry Partners on sites' workforce and inflationary challenges, and what they took away from the SCRS Global Site Solutions Summit.

SCRS is hosting the second annual Diversity Site Solutions Summit in a few short weeks! Jackie Kent, VP of Strategy and Special Projects and Diversity with SCRS, and Kim Ribeiro, Head of Diversity & Patient Inclusion at AbbVie and co-chair of the SCRS Diversity Awareness Program discuss why an event like this is important for the industry, what makes this year's Summit different, and some of the exciting sessions to look forward to.  

SCRS Oncology Program participants Peter Fredette, Director, Clinical Partnerships Liaison with EQRx and Dan Otap, Principal, Alliance and Partnerships Lead at Genentech share information about helpful oncology resources for sites as well as some exciting new topics they are looking forward to discussing at this year's Global Oncology Site Solutions Summit.

If your site participates in oncology research, be sure to make your voice heard in the Oncology Site Landscape Survey today!